{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:41:17Z","timestamp":1759761677526,"version":"build-2065373602"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hardiman Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01305-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:17:53Z","timestamp":1759756673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cWe knew it was coming: we didn\u2019t act\u201d perspectives from people who use drugs and substance use workforce on the impact of delays in implementation of the supervised injection facility and drug checking interventions"],"prefix":"10.1186","volume":"22","author":[{"given":"Margaret R.","family":"Hester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaclyn M. W.","family":"Hughto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Ravikumar-Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saoirse","family":"Nic Gabhainn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"1305_CR1","unstructured":"EUDA. European Union Drugs Agency. [cited 2025 Jan 8]. Overdose situation (FAQ drug overdose deaths in Europe). Available from: https:\/\/www.euda.europa.eu\/publications\/topic-overviews\/drug-induced-deaths-faq\/overdose-situation_en"},{"key":"1305_CR2","unstructured":"Department of Health. Reducing harm, supporting recovery: a health-led response to drug and alcohol use in Ireland 2017\u20132025. Dublin; 2017 [cited 2024 Jun 26]. Available from: https:\/\/www.drugsandalcohol.ie\/27603\/"},{"issue":"5","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.amepre.2021.04.017","volume":"61","author":"TW Levengood","year":"2021","unstructured":"Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, et al. Supervised injection facilities as harm reduction: a systematic review. Am J Prev Med. 2021;61(5):738\u201349.","journal-title":"Am J Prev Med"},{"issue":"3","key":"1305_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532\u201344.","journal-title":"Addiction"},{"key":"1305_CR5","unstructured":"Ryan \u00d3. Ireland\u2019s first medically supervised injection centre to open, nine years after it was approved. The Journal. 2024 Dec 17 [cited 2025 Jul 17]; Available from: https:\/\/www.thejournal.ie\/medically-supervised-injection-centre-opens-in-dublin-6568830-Dec2024\/"},{"key":"1305_CR6","unstructured":"HSE National Social Inclusion Office. Supervised Injecting Facilities. [cited 2022 Mar 16]. Available from: https:\/\/www.hse.ie\/eng\/about\/who\/primarycare\/socialinclusion\/addiction\/supervised-injecting-centre\/"},{"issue":"Jul","key":"1305_CR7","doi-asserted-by":"publisher","first-page":"104049","DOI":"10.1016\/j.drugpo.2023.104049","volume":"117","author":"NM Miller","year":"2023","unstructured":"Miller NM, Campbell C, Shorter GW. Barriers and facilitators of naloxone and safe injection facility interventions to reduce opioid drug-related deaths: a qualitative analysis. Int J Drug Policy. 2023;117(Jul):104049.","journal-title":"Int J Drug Policy"},{"key":"1305_CR8","unstructured":"Neylon L. Six years on there\u2019s still no timeline for the opening of the first supervised injecting facility in Dublin. Dublin Inquirer. 2023 Jul 16 [cited 2025 Jul 2]; Available from: https:\/\/www.dublininquirer.com\/six-years-on-theres-still-no-timeline-for-the-opening-of-first-supervised-injecting-facility-in-dublin\/"},{"key":"1305_CR9","unstructured":"Killeen N, McNamara S, Stokes S, Keenan E. Safer nightlife programme 2022: results from \u2018back of house\u2019 drug testing. Dublin; 2022 [cited 2023 Jan 18]. Available from: https:\/\/www.drugsandalcohol.ie\/37339\/1\/Safer%20Nightlife%20Programme%202022%20%283%29.pdf"},{"key":"1305_CR10","unstructured":"Drug and Alcohol Information and Support. Drugs.ie. [cited 2025 Jul 7]. Reduce the harms at festivals. Available from: https:\/\/drugs.ie\/festivals"},{"issue":"1","key":"1305_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugpo.2007.11.017","volume":"20","author":"A Ritter","year":"2009","unstructured":"Ritter A. How do drug policy makers access research evidence? Int J Drug Policy. 2009;20(1):70\u20135.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1305_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/09687637.2010.493540","volume":"18","author":"N Randall","year":"2011","unstructured":"Randall N. Drug policy and rationality: an exploration of the research\u2013policy interface in Ireland. Drugs Educ Prev Policy. 2011;18(4):285\u201394.","journal-title":"Drugs Educ Prev Policy"},{"issue":"6","key":"1305_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.drugpo.2005.07.002","volume":"16","author":"S Butler","year":"2005","unstructured":"Butler S, Maycock P. \u2018An Irish Solution to an Irish Problem\u2019: harm reduction and ambiguity in the drug policy of the Republic of Ireland. Int J Drug Policy. 2005;16(6):415\u201322.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1305_CR14","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/sus.2020.13","volume":"1","author":"WF Lamb","year":"2020","unstructured":"Lamb WF, Mattioli G, Levi S, Roberts JT, Capstick S, Creutzig F, et al. Discourses of climate delay. Glob Sustain. 2020;1(3):e17.","journal-title":"Glob Sustain"},{"key":"1305_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s13280-025-02207-8","author":"N Pietarinen","year":"2025","unstructured":"Pietarinen N, Pecurul-Botines M, Brockhaus M. Politics of delay hinder the implementation of EU forest strategy in Finland. Ambio. 2025. https:\/\/doi.org\/10.1007\/s13280-025-02207-8.","journal-title":"Ambio"},{"issue":"3","key":"1305_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/psq.12473","volume":"48","author":"S Thrower","year":"2018","unstructured":"Thrower S. Policy disruption through regulatory delay in the trump administration. Pres Stud Q. 2018;48(3):517\u201336.","journal-title":"Pres Stud Q"},{"issue":"3","key":"1305_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s11077-021-09432-4","volume":"54","author":"I Stadelmann-Steffen","year":"2021","unstructured":"Stadelmann-Steffen I, Oehrli D, Vatter A. Do governments delay the implementation of parliamentary requests? Examining time variation in implementing legislative requests in Switzerland. Policy Sci. 2021;54(3):663\u201390.","journal-title":"Policy Sci"},{"key":"1305_CR18","unstructured":"Kingdon J. Agendas, Alternatives, and Public Policies. Second edition. Harlow, England: Pearson new international; 2013"},{"issue":"2\u20133","key":"1305_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00136406","volume":"21","author":"PA Sabatier","year":"1988","unstructured":"Sabatier PA. An advocacy coalition framework of policy change and the role of policy-oriented learning therein. Policy Sci. 1988;21(2\u20133):129\u201368.","journal-title":"Policy Sci"},{"issue":"6","key":"1305_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/jech.2005.037333","volume":"60","author":"L de la Fuente","year":"1978","unstructured":"de la Fuente L. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. J Epidemiol Commun Health. 1978;60(6):537\u201342.","journal-title":"J Epidemiol Commun Health"},{"issue":"1","key":"1305_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12954-022-00602-y","volume":"19","author":"J Holeksa","year":"2022","unstructured":"Holeksa J. Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city. Harm Reduct J. 2022;19(1):23.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1305_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-019-0305-7","volume":"16","author":"ST Allen","year":"2019","unstructured":"Allen ST, Grieb SM, O\u2019Rourke A, Yoder R, Planchet E, White RH, et al. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):33.","journal-title":"Harm Reduct J"},{"key":"1305_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addbeh.2018.03.014","volume":"86","author":"C McClellan","year":"2018","unstructured":"McClellan C, Lambdin BH, Ali MM, Mutter R, Davis CS, Wheeler E, et al. Opioid-overdose laws association with opioid use and overdose mortality. Addict Behav. 2018;86:90\u20135.","journal-title":"Addict Behav"},{"key":"1305_CR24","unstructured":"SAMHSA\u2019S Center for the Application of Prevention Technologies. Preventing Opioid Overdose: Understanding Good Samaritan Laws. 2017 Nov. Available from: https:\/\/www.drugsandalcohol.ie\/28261\/1\/SAMHSA_good-samaritan-law-tool.pdf"},{"issue":"5","key":"1305_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/145507251002700505","volume":"27","author":"A Hope","year":"2010","unstructured":"Hope A, Butler S. Changes in consumption and harms, yet little policy progress: trends in alcohol consumption, harms and policy: Ireland 1990\u20132010. Nord Stud Alcohol Drugs. 2010;27(5):479\u201396.","journal-title":"Nord Stud Alcohol Drugs"},{"key":"1305_CR26","first-page":"22","volume":"47","author":"S Lyons","year":"2013","unstructured":"Lyons S. Proposed regulatory framework for buprenorphine\/naloxone products in Ireland. Drugnet Irel. 2013;47:22\u20133.","journal-title":"Drugnet Irel"},{"key":"1305_CR27","unstructured":"Cullen P. Methadone alternative to be made available to drug addicts\u2014the Irish times. The Irish Times. 2016 [cited 2022 Aug 31]; Available from: https:\/\/www.irishtimes.com\/business\/health-pharma\/methadone-alternative-to-be-made-available-to-drug-addicts-1.2674906"},{"issue":"1","key":"1305_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12875-018-0792-8","volume":"19","author":"MC Van Hout","year":"2018","unstructured":"Van Hout MC, Crowley D, McBride A, Delargy I. Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland. BMC Fam Pract. 2018;19(1):103.","journal-title":"BMC Fam Pract"},{"key":"1305_CR29","unstructured":"Rooney A. Merchants Quay Ireland welcomes development of negotiations for wider availability of suboxone. Merchants Quay Ireland. 2018 [cited 2025 Jul 17]. Available from: https:\/\/mqi.ie\/merchants-quay-ireland-welcomes-development-of-negotiations-for-wider-availability-of-suboxone\/"},{"key":"1305_CR30","doi-asserted-by":"publisher","first-page":"103768","DOI":"10.1016\/j.drugpo.2022.103768","volume":"106","author":"L Durand","year":"2022","unstructured":"Durand L, Keenan E, Boland F, Harnedy N, Delargy \u00cd, Scully M, et al. Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: a national Delphi study. Int J Drug Policy. 2022;106:103768.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1305_CR31","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s12889-019-7389-6","volume":"19","author":"K Oliver","year":"2019","unstructured":"Oliver K, Lorenc T, Tinkler J, Bonell C. Understanding the unintended consequences of public health policies: the views of policymakers and evaluators. BMC Public Health. 2019;19(1):1057.","journal-title":"BMC Public Health"},{"issue":"1","key":"1305_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/capr.12360","volume":"21","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. Can I use TA? Should I use TA? Should I not use TA? Comparing reflexive thematic analysis and other pattern-based qualitative analytic approaches. Couns Psychother Res. 2021;21(1):37\u201347.","journal-title":"Couns Psychother Res"},{"issue":"3","key":"1305_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","volume":"18","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qual Res Psychol. 2021;18(3):328\u201352.","journal-title":"Qual Res Psychol"},{"key":"1305_CR34","unstructured":"Picken A. Delay to drug checking services for Scottish cities. BBC Scotland News. 2023 Mar 17 [cited 2024 Dec 9]; Available from: https:\/\/www.bbc.com\/news\/uk-scotland-64989182"},{"key":"1305_CR35","doi-asserted-by":"publisher","first-page":"103670","DOI":"10.1016\/j.drugpo.2022.103670","volume":"104","author":"GW Shorter","year":"2022","unstructured":"Shorter GW, Harris M, McAuley A, Trayner KM, Stevens A. The United Kingdom\u2019s first unsanctioned overdose prevention site; a proof-of-concept evaluation. Int J Drug Policy. 2022;104:103670.","journal-title":"Int J Drug Policy"},{"key":"1305_CR36","doi-asserted-by":"publisher","first-page":"p2238","DOI":"10.1136\/bmj.p2238","volume":"27","author":"B Christie","year":"2023","unstructured":"Christie B. Safe space for injecting drugs is approved in Scotland. BMJ. 2023;27:p2238.","journal-title":"BMJ"},{"issue":"1","key":"1305_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13011-017-0125-2","volume":"12","author":"K Rudzinski","year":"2017","unstructured":"Rudzinski K, McDonough P, Gartner R, Strike C. Is there room for resilience? A scoping review and critique of substance use literature and its utilization of the concept of resilience. Subst Abuse Treat Prev Policy. 2017;12(1):41.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1305_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugpo.2018.08.004","volume":"60","author":"C McKnight","year":"2018","unstructured":"McKnight C, Des Jarlais DC. Being \u201chooked up\u201d during a sharp increase in the availability of illicitly manufactured fentanyl: adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82\u20138.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1305_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41562-023-01575-z","volume":"7","author":"PJA Kelly","year":"2023","unstructured":"Kelly PJA, Biello KB, Hughto JMW. Makeshift medicine is a response to US health system failures. Nat Hum Behav. 2023;7(4):475\u20137.","journal-title":"Nat Hum Behav"},{"key":"1305_CR40","unstructured":"HSE. Our National Service Plan 2024. Dublin; 2024 [cited 2024 Dec 12]. p. 29. Available from: https:\/\/about.hse.ie\/api\/v2\/download-file\/file_based_publications\/hse-national-service-plan-2024.pdf\/"},{"key":"1305_CR41","unstructured":"Michelow W, Dowden C. \u201cStart small, take it easy\u201d Results from the ANKORS harm reduction survey at the 2013 Shambhala music festival. 2015 Feb [cited 2024 Oct 16]. Available from: https:\/\/michelow.ca\/doc\/ankors-2013-smf-survey-report.pdf"},{"key":"1305_CR42","doi-asserted-by":"publisher","first-page":"103293","DOI":"10.1016\/j.drugpo.2021.103293","volume":"95","author":"RPJ Koning","year":"2021","unstructured":"Koning RPJ, Benschop A, Wijffels C, Noijen J. Visitors of the Dutch drug checking services: profile and drug use experience. Int J Drug Policy. 2021;95:103293.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1305_CR43","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s11845-021-02765-2","volume":"191","author":"JH Ivers","year":"2022","unstructured":"Ivers JH, Killeen N, Keenan E. Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers. Irish J Med Sci. 2022;191(4):1701\u201310.","journal-title":"Irish J Med Sci."},{"key":"1305_CR44","unstructured":"Ivers JH, Barry J. Mortality amongst the homeless population in Dublin. Dublin; 2018. Available from: http:\/\/drugs.ie\/images\/uploads\/Mortality_amongst_the_homeless_population_in_Dublin_(3).pdf"},{"key":"1305_CR45","unstructured":"O\u2019Reilly L, Mac Cionnaith C. Crack cocaine use in Ballymun: An evidence base for interventions. Dublin; 2019 [cited 2024 Oct 17]. Available from: https:\/\/www.drugsandalcohol.ie\/31345\/1\/Ballymundtf%20Report%20Book%20online.pdf"},{"key":"1305_CR46","unstructured":"Health Research Board. HRB reports sustained rise in demand for cocaine treatment. 2024 Jun [cited 2024 Oct 15]. Available from: https:\/\/www.hrb.ie\/press-releases\/addiction-treatment-ndtrs-press-releases\/hrb-reports-sustained-rise-in-demand-for-cocaine-treatment\/"},{"key":"1305_CR47","doi-asserted-by":"publisher","first-page":"103589","DOI":"10.1016\/j.drugpo.2022.103589","volume":"102","author":"ND Gehring","year":"2022","unstructured":"Gehring ND, Speed KA, Launier K, O\u2019Brien D, Campbell S, Hyshka E. The state of science on including inhalation within supervised consumption services: a scoping review of academic and grey literature. Int J Drug Policy. 2022;102:103589.","journal-title":"Int J Drug Policy"},{"key":"1305_CR48","unstructured":"Byrne L. Fentanyl: Could the killer drug reach our streets? RTE. 2023 Oct 17 [cited 2025 Jul 17]; Available from: https:\/\/www.rte.ie\/news\/primetime\/2023\/1017\/1411223-fentanyl-could-the-killer-drug-reach-our-streets\/"},{"key":"1305_CR49","unstructured":"Health Service Executive. HSE. 2023 [cited 2023 Dec 6]. Nitazenes detected in heroin samples related to Dublin Overdose cluster. Available from: https:\/\/www.hse.ie\/eng\/services\/news\/media\/pressrel\/nitazenes-detected-in-heroin-samples-related-to-dublin-overdose-cluster.html"},{"key":"1305_CR50","unstructured":"O\u2019Keefe C. Alert as deadly opiate nitazene is found in fake sedative tablets. Irish Examiner [Internet]. 2024 Jun 14 [cited 2024 Jul 3]; Available from: https:\/\/www.irishexaminer.com\/news\/arid-41416816.html"},{"key":"1305_CR51","doi-asserted-by":"publisher","first-page":"108416","DOI":"10.1016\/j.drugalcdep.2020.108416","volume":"218","author":"JN Park","year":"2021","unstructured":"Park JN, Rashidi E, Foti K, Zoorob M, Sherman S, Alexander GC. Fentanyl and fentanyl analogs in the illicit stimulant supply: results from U.S. drug seizure data, 2011\u20132016. Drug Alcohol Depend. 2021;218:108416.","journal-title":"Drug Alcohol Depend"},{"key":"1305_CR52","doi-asserted-by":"publisher","first-page":"110985","DOI":"10.1016\/j.drugalcdep.2023.110985","volume":"252","author":"KD Wagner","year":"2023","unstructured":"Wagner KD, Fiuty P, Page K, Tracy EC, Nocera M, Miller CW, et al. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services. Drug Alcohol Depend. 2023;252:110985.","journal-title":"Drug Alcohol Depend"},{"key":"1305_CR53","doi-asserted-by":"crossref","unstructured":"Klar SA, Brodkin E, Gibson E, Padhi S, Predy C, Green C, et al. Furanyl-fentanyl overdose events caused by smoking contaminated crack cocaine\u2014British Columbia, Canada, July 15\u201318, 2016 [Internet]. 2016 Sep [cited 2024 Jul 3]. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/pdfs\/mm6537.pdf#page=23","DOI":"10.15585\/mmwr.mm6537a6"},{"issue":"3","key":"1305_CR54","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/cpt.2027","volume":"109","author":"MH Algera","year":"2021","unstructured":"Algera MH, Olofsen E, Moss L, Dobbins RL, Niesters M, van Velzen M, et al. Tolerance to opioid-induced respiratory depression in chronic high-dose opioid users: a model-based comparison with opioid-na\u00efve individuals. Clin Pharmacol Ther. 2021;109(3):637\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"1305_CR55","doi-asserted-by":"publisher","first-page":"103147","DOI":"10.1016\/j.drugpo.2021.103147","volume":"92","author":"MK Reed","year":"2021","unstructured":"Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. \u201cI probably got a minute\u201d: perceptions of fentanyl test strip use among people who use stimulants. Int J Drug Policy. 2021;92:103147.","journal-title":"Int J Drug Policy"},{"key":"1305_CR56","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","volume":"61","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52\u20138.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1305_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","volume":"63","author":"NC Peiper","year":"2019","unstructured":"Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63(1):122\u20138.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1305_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/09687630600911684","volume":"14","author":"M O\u2019Shea","year":"2007","unstructured":"O\u2019Shea M. Introducing safer injecting facilities (SIFs) in the Republic of Ireland: \u2018Chipping away\u2019 at policy change. Drugs Educ Prev Policy. 2007;14(1):75\u201388.","journal-title":"Drugs Educ Prev Policy"},{"key":"1305_CR59","doi-asserted-by":"publisher","first-page":"114116","DOI":"10.1016\/j.socscimed.2021.114116","volume":"282","author":"M Lesch","year":"2021","unstructured":"Lesch M, McCambridge J. Waiting for the wave: political leadership, policy windows, and alcohol policy change in Ireland. Soc Sci Med. 2021;282:114116.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1305_CR60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12954-022-00680-y","volume":"19","author":"C Matheson","year":"2022","unstructured":"Matheson C, Robertson R. An avoidable crisis. Harm Reduct J. 2022;19(1):98.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1305_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12954-025-01238-4","volume":"22","author":"BE Pridgen","year":"2025","unstructured":"Pridgen BE, Bontemps AP, Lloyd AR, Wagner WP, Kay ES, Eaton EF, et al. US substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations. Harm Reduct J. 2025;22(1):101.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1305_CR62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/13562576.2016.1140403","volume":"20","author":"A Longhurst","year":"2016","unstructured":"Longhurst A, McCann E. Political struggles on a frontier of harm reduction drug policy: geographies of constrained policy mobility. Space Polity. 2016;20(1):109\u201323.","journal-title":"Space Polity"},{"key":"1305_CR63","doi-asserted-by":"publisher","first-page":"102615","DOI":"10.1016\/j.drugpo.2019.102615","volume":"76","author":"TM Watson","year":"2020","unstructured":"Watson TM, Kolla G, van der Meulen E, Dodd Z. Critical studies of harm reduction: overdose response in uncertain political times. Int J Drug Policy. 2020;76:102615.","journal-title":"Int J Drug Policy"},{"key":"1305_CR64","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.ssmqr.2022.100090","volume":"2","author":"BM Stifani","year":"2022","unstructured":"Stifani BM, Mishtal J, Chavkin W, Reeves K, Grimes L, Chakravarty D, et al. Abortion policy implementation in Ireland: successes and challenges in the establishment of hospital-based services. SSM Qual Res Health. 2022;2:100090.","journal-title":"SSM Qual Res Health"},{"key":"1305_CR65","unstructured":"NWC. National Women\u2019s Council. 2025 [cited 2025 Jul 30]. Seven years after Repeal at least 240 women are still travelling for abortion care every year. Available from: https:\/\/www.nwci.ie\/learn\/article\/seven_years_after_repeal_at_least_240_women_are_still_travelling_for_aborti#:~:text=%E2%80%9CNWC%20welcomed%20that%20from%202025,every%20county%20providing%20abortion%20care"},{"key":"1305_CR66","unstructured":"Report of the Citizens\u2019 Assembly on drugs use volume I. Dublin; 2024 Jan [cited 2024 Oct 17]. Available from: https:\/\/citizensassembly.ie\/wp-content\/uploads\/CADU_Volume1.pdf"},{"key":"1305_CR67","unstructured":"Joint Committee on Drugs Use. Interim report. 2024 Oct [cited 2025 Aug 28]. Available from: https:\/\/data.oireachtas.ie\/ie\/oireachtas\/committee\/dail\/33\/joint_committee_on_drugs_use\/reports\/2024\/2024-10-22_joint-committee-on-drug-use-interim-report_en.pdf"},{"issue":"S2","key":"1305_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1073110519857328","volume":"47","author":"G Sunshine","year":"2019","unstructured":"Sunshine G, Barrera N, Corcoran AJ, Penn M. Emergency declarations for public health issues: expanding our definition of emergency. J Law Med Ethics. 2019;47(S2):95\u20139.","journal-title":"J Law Med Ethics"},{"issue":"4","key":"1305_CR69","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.hlpt.2020.08.021","volume":"9","author":"B Kennelly","year":"2020","unstructured":"Kennelly B, O\u2019Callaghan M, Coughlan D, Cullinan J, Doherty E, Glynn L, et al. The COVID-19 pandemic in Ireland: an overview of the health service and economic policy response. Health Policy Technol. 2020;9(4):419\u201329.","journal-title":"Health Policy Technol"},{"key":"#cr-split#-1305_CR70.1","unstructured":"Houses of the Oireachtas. Planning and Development Act 2000 (Exempted Development) (No. 2) Regulations 2022: Motion. Vol. 1020, D\u00e1il \u00c9ireann debate-Tuesday, 29 Mar 2022 Vol. 1020 No. 2. Dublin"},{"key":"#cr-split#-1305_CR70.2","unstructured":"2022 [cited 2025 Jul 4]. Available from: https:\/\/www.oireachtas.ie\/en\/debates\/debate\/dail\/2022-03-29\/14\/"},{"key":"1305_CR71","doi-asserted-by":"publisher","first-page":"102966","DOI":"10.1016\/j.drugpo.2020.102966","volume":"87","author":"A O\u2019Carroll","year":"2021","unstructured":"O\u2019Carroll A, Duffin T, Collins J. Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland. Int J Drug Policy. 2021;87:102966.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1305_CR72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/14413582241264619","volume":"33","author":"WM Lim","year":"2025","unstructured":"Lim WM. What is qualitative research? An overview and guidelines. Australas Mark J. 2025;33(2):199\u2013229.","journal-title":"Australas Mark J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01305-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01305-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01305-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:07:34Z","timestamp":1759759654000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01305-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01305-w","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Full ethical approval was granted by the first author\u2019s university\u2019s Research Ethics Committee. Informed consent was obtained from all participants included in this study. Verbal consent was sought prior to recording interviews and once again at the start of the interview recording.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}